Lung Cancer Trial, Not Yet Recruiting NCT06739031 Sponsor: Energenx Medical LTD. Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT06739031
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are 18 years of age or older.
  • People who have been diagnosed with non-small cell lung cancer, where the tumour is no larger than 3 cm across and there are no more than 3 tumours.
  • People whose general health and ability to carry out daily activities meets a certain standard (known as an ECOG score of 2 or less — confirm with trial site).
  • People whose tumour(s) the treating doctor considers suitable for an ablation procedure (a treatment that destroys tumour tissue).
  • People who agree to receive the ablation treatment and sign a consent form.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who cannot tolerate general anaesthesia, or who do not wish to have it.
  • People who have a history of severe allergic reactions.
  • People who have medical reasons preventing a bronchoscopy procedure (a procedure to look inside the airways), or who do not wish to have one.
  • People who have active implanted devices in the chest, or metal implants in the lung being treated.
  • People with blood clotting problems that cannot be corrected, a tendency to bleed, or a very low platelet count (below 50×10⁹/L), including those who have not stopped blood-thinning or antiplatelet medications for the required time before the procedure.
  • People with serious liver or kidney problems, assessed by the treating doctor as unsuitable for the trial.
  • People with an active infection that cannot be effectively controlled.
  • People with other serious lung conditions (such as severe interstitial pneumonia, pulmonary fibrosis, or collapsed lung), assessed by the treating doctor as unsuitable for the trial.
  • People who have had a serious heart or brain event (such as a heart attack or stroke) within the past 3 months.
  • People with serious heart problems, including severe heart failure, certain abnormal heart rhythms in the past 2 years, certain types of heart block, or a resting heart rate below 45 beats per minute.
  • People who have taken part in another clinical trial within the past 3 months, or are currently in one.
  • People who are pregnant, breastfeeding, or planning to become pregnant during the study period.
  • People whom the treating doctor considers unsuitable for the trial for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 021

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Energenx Medical LTD.
Registry
ClinicalTrials.gov
Start date
25 December 2024
Est. completion
25 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

6-month complete ablation rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov